Qingjiang Xu

Chinese PLA General Hospital

Papers

1

Total Citations

3

H-Index

1

About

Dr. Qingjiang Xu is a leading urologic surgeon and researcher whose work centers on advanced minimally invasive techniques for renal cell carcinoma, particularly cases involving venous tumor thrombus extension. His most impactful contribution is the landmark single-center study on robot-assisted nephrectomy and venous tumor thrombectomy (RA-N-VTT), which established critical indications and surgical strategies for this complex procedure. Drawing from a high-volume experience of 309 patients, Dr. Xu’s research has been instrumental in demonstrating the safety and long-term efficacy of robotic approaches for what was once considered an exclusively open-surgery domain. His work has garnered significant attention, with his flagship paper accumulating citations that underscore its influence on clinical practice. By systematically evaluating outcomes and refining surgical protocols, Dr. Xu has helped expand the boundaries of robotic urologic oncology, offering patients less invasive options with comparable oncologic control. His contributions continue to shape surgical decision-making and training for managing advanced renal tumors with vascular involvement.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Single-Center Experience of Robot-Assisted Nephrectomy and Venous Tumor Thrombectomy: Indications, Surgical Strategies, and Long-Term Outcomes
3 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 19
🏛 Institutions: Chinese PLA General Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago